In particular, we used a CAM model to monitor tumor behavior and a CRISPR-based knockout model in CTCL cells to provide important insights into the role of OX-40 in CTCL progression. This evidence concerns the gene TNFRSF4 and primary cutaneous T-cell non-Hodgkin lymphoma.